BML Inc operates in the Medical laboratories sector.
In addition to historical fundamental analyses, the complete report available to purchase compares BML Inc with three other
pharmaceutical manufacturers in Asia:
Zhejiang DiAn Diagnostics Co Ltd
sales of 1.86 billion Chinese Renmimbi [US$286.98 million]
of which 59%
Hangzhou Tigermed Consulting Co Ltd
(956.97 million Chinese Renmimbi [US$147.81 million]
of which 95%
was Service), and
Falco Holdings Co Ltd
(46.59 billion Japanese Yen [US$437.97 million]
of which 62%
was Medical Test).
BML Inc reported sales of ¥104.40 billion (US$981.40 million)
March of 2015.
increase of 5.4%
versus 2014, when the company's sales were ¥99.05 billion.
Sales at BML Inc have increased during each of the previous five years
(and since 2010, sales have increased a total of 32%).